Posts relating to PHE Priority 7: Developing our own capacity and capability
...rate at which our medical microbiology is modernising. Of course, these days our Information and Communications Technology (ICT) is at the very heart of everything that we do. This may...
...great idea, but may not fit with the company’s strategy. An open innovation approach would suggest perhaps setting up a spinout company, licensing or franchising out the innovation, or working...
...means my team in Bristol see a little more of me these days, and colleagues in Centres (and hopefully soon in other organisations like local authorities and NHS England) can...
Having started my career as a trainee accountant at South Tyneside Council nearly 25 years ago and returned after a time elsewhere in the public sector to have a stint as Head of Finance, local government still feels like my …
...England and whether organisational development makes a difference. A year ago the then-shadow National Executive received an initial organisational development plan with the theme 'great expectations'. Based on a series...
...if they had to build these capabilities from scratch. In the life sciences sector, quality assurance is critically important. By offering our testing and quality assurance capabilities to industry (for...
...take all opportunities to develop and strengthen our contribution to improved public health outcomes. Nurses are already coming forward to populate some of the strategic groups at PHE to ensure...
...PHE’s Business Development community, as our spinout company Syntaxin has been successfully acquired by Ipsen and we have issued our first licence for PHE polio vaccine technology to GSK. On...
When I spoke recently at the first annual Public Health England conference, I described it as a very special conference. It was a special conference, I said, because it finally...
